These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26376741)

  • 1. Immunotherapy of Brain Tumors.
    Dutoit V; Migliorini D; Walker PR; Dietrich PY
    Prog Tumor Res; 2015; 42():11-21. PubMed ID: 26376741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for glioma: from illusion to realistic prospects?
    Dietrich PY; Dutoit V; Walker PR
    Am Soc Clin Oncol Educ Book; 2014; ():51-9. PubMed ID: 24857060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma-specific antigens for immune tumor therapy.
    Skog J
    Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain tumor immunotherapy: Illusion or hope?].
    Migliorini D; Dutoit V; Walker PR; Dietrich PY
    Bull Cancer; 2017 May; 104(5):476-484. PubMed ID: 28318492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of Breast Cancer.
    Criscitiello C; Curigliano G
    Prog Tumor Res; 2015; 42():30-43. PubMed ID: 26377084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of Melanoma.
    Snyder A; Zamarin D; Wolchok JD
    Prog Tumor Res; 2015; 42():22-9. PubMed ID: 26376963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of EGFRvIII as the target for glioma vaccines.
    Lowenstein PR; Castro MG
    Am Soc Clin Oncol Educ Book; 2014; ():42-50. PubMed ID: 24857059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
    Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein.
    Crane CA; Han SJ; Ahn B; Oehlke J; Kivett V; Fedoroff A; Butowski N; Chang SM; Clarke J; Berger MS; McDermott MW; Prados MD; Parsa AT
    Clin Cancer Res; 2013 Jan; 19(1):205-14. PubMed ID: 22872572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches in ovarian cancer vaccines.
    Reinartz S; Wagner U
    Minerva Ginecol; 2004 Dec; 56(6):515-27. PubMed ID: 15729204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel chemotherapeutics and other therapies for treating high-grade glioma.
    Kang JH; Adamson C
    Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H; Husain SR; Puri RK
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
    Yu JS; Luptrawan A; Black KL; Liu G
    Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for glioma: getting closer to the clinical arena?
    Finocchiaro G; Pellegatta S
    Curr Opin Neurol; 2011 Dec; 24(6):641-7. PubMed ID: 22027543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future approaches in immunotherapy.
    Rini B
    Semin Oncol; 2014 Oct; 41 Suppl 5():S30-40. PubMed ID: 25438998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
    Yamanaka R; Xanthopoulos KG
    DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
    Spigel DR; Socinski MA
    J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.